In summary, the present study demonstrates that miR‐145 plays an important role in inhibiting cell migration by directly targeting PAK4, and identifies miR‐145‐PAK4‐LIMK1‐cofilin as a novel regulatory pathway that contributed to CRC metastasis. Here, LIMK1 is linked to colorectal carcinoma.